MAYLEBEN TIMOTHY M
Insider CIK 1242613 · MRNS Director · ESPR President and CEO, Director · LOXO Director · LABP Interim CEO, Director · ASTM President and CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MRNS MARINUS PHARMACEUTICALS, I | D To issuer deriv | 2025-02-11 | 2025-02-11 | 10,450 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | D To issuer deriv | 2025-02-11 | 2025-02-11 | 20,900 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | D To issuer deriv | 2025-02-11 | 2025-02-11 | 16,200 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | D To issuer deriv | 2025-02-11 | 2025-02-11 | 12,375 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | D To issuer deriv | 2025-02-11 | 2025-02-11 | 16,500 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | D To issuer deriv | 2025-02-11 | 2025-02-11 | 25,000 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | D To issuer deriv | 2025-02-11 | 2025-02-11 | 8,750 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | D To issuer deriv | 2025-02-11 | 2025-02-11 | 8,750 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | D To issuer deriv | 2025-02-11 | 2025-02-11 | 2,625 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | D To issuer deriv | 2025-02-11 | 2025-02-11 | 1,575 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | D To issuer deriv | 2025-02-11 | 2025-02-11 | 1,925 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | D To issuer | 2025-02-11 | 2025-02-11 | 2,300 | $0.55 | $1.3K | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | D To issuer | 2025-02-07 | 2025-02-11 | 1,660 | $0.55 | $913 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | D To issuer | 2025-02-07 | 2025-02-11 | 10,637 | $0.55 | $5.9K | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | D To issuer | 2025-02-07 | 2025-02-11 | 4,600 | $0.55 | $2.5K | 2,300 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | D To issuer | 2025-02-07 | 2025-02-11 | 1,660 | $0.55 | $913 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | G Gift | 2024-10-10 | 2024-10-15 | 4,980 | — | $0 | 13,957 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | G Gift | 2024-10-10 | 2024-10-15 | 1,660 | — | $0 | 10,637 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | G Gift | 2024-10-10 | 2024-10-15 | 1,660 | — | $0 | 12,297 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | A Award deriv | 2024-06-18 | 2024-06-20 | 10,450 | — | $0 | 10,450 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | A Award | 2024-06-18 | 2024-06-20 | 2,300 | — | $0 | 24,375 | SEC↗ |
| LABP Landos Biopharma, Inc. | D To issuer deriv | 2024-05-23 | 2024-05-23 | 1,800 | — | $0 | 0 | SEC↗ |
| LABP Landos Biopharma, Inc. | D To issuer deriv | 2024-05-23 | 2024-05-23 | 1,800 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | A Award deriv | 2024-01-18 | 2024-01-19 | 20,900 | — | $0 | 20,900 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | A Award | 2024-01-18 | 2024-01-19 | 4,600 | — | $0 | 22,075 | SEC↗ |
| LABP Landos Biopharma, Inc. | A Award deriv | 2023-05-23 | 2023-05-24 | 18,000 | — | $0 | 18,000 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | A Award deriv | 2023-01-26 | 2023-01-30 | 16,200 | — | $0 | 16,200 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | A Award | 2023-01-26 | 2023-01-30 | 3,600 | — | $0 | 17,475 | SEC↗ |
| LABP Landos Biopharma, Inc. | A Award deriv | 2022-06-17 | 2022-06-22 | 18,000 | — | $0 | 18,000 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | A Award deriv | 2022-02-04 | 2022-02-07 | 12,375 | — | $0 | 12,375 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | A Award | 2022-02-04 | 2022-02-07 | 2,750 | — | $0 | 13,875 | SEC↗ |
| LABP Landos Biopharma, Inc. | A Award deriv | 2021-12-17 | 2021-12-21 | 253,485 | — | $0 | 253,485 | SEC↗ |
| LABP Landos Biopharma, Inc. | A Award deriv | 2021-05-13 | 2021-05-17 | 36,000 | — | $0 | 36,000 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2021-01-28 | 2021-01-29 | 175,000 | — | $0 | 175,000 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | A Award deriv | 2021-01-15 | 2021-01-19 | 16,500 | — | $0 | 16,500 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | M Exercise deriv | 2020-12-30 | 2020-12-31 | 10,700 | — | $0 | 262,959 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | M Exercise | 2020-12-30 | 2020-12-31 | 10,700 | $2.10 | $22.5K | 122,698 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | P Buy | 2020-03-11 | 2020-03-12 | 2,500 | $43.00 | $107.5K | 111,998 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | P Buy | 2020-02-28 | 2020-03-02 | 5,000 | $49.00 | $245.0K | 109,498 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | A Award deriv | 2020-01-08 | 2020-01-10 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2020-01-02 | 2020-01-03 | 104,175 | — | $0 | 104,175 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award | 2020-01-02 | 2020-01-03 | 23,150 | — | $0 | 104,498 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | G Gift | 2019-11-15 | 2020-01-03 | 365 | — | $0 | 81,348 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | G Gift | 2019-11-11 | 2020-01-03 | 1,950 | — | $0 | 81,173 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | P Buy | 2019-11-06 | 2019-11-08 | 5,000 | $36.98 | $184.9K | 83,663 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | P Buy | 2019-09-06 | 2019-09-06 | 2,500 | $35.25 | $88.1K | 78,663 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | P Buy | 2019-09-04 | 2019-09-06 | 148 | $33.42 | $4.9K | 76,163 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | P Buy | 2019-09-04 | 2019-09-06 | 4,852 | $34.22 | $166.0K | 76,015 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | P Buy | 2019-08-01 | 2019-08-02 | 5,000 | $39.56 | $197.8K | 71,163 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | P Buy | 2019-06-28 | 2019-07-01 | 5,000 | $46.00 | $230.0K | 66,163 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | P Buy | 2019-03-29 | 2019-04-01 | 5,000 | $40.00 | $200.0K | 61,163 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | P Buy | 2019-03-20 | 2019-03-21 | 5,000 | $43.48 | $217.4K | 56,163 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | P Buy | 2019-03-14 | 2019-03-14 | 5,000 | $48.73 | $243.6K | 51,163 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | A Award deriv | 2019-02-26 | 2019-02-28 | 35,000 | — | $0 | 35,000 | SEC↗ |
| LOXO Loxo Oncology, Inc. | D To issuer deriv | 2019-02-15 | 2019-02-15 | 8,750 | $235.00 | $2.06M | 0 | SEC↗ |
| LOXO Loxo Oncology, Inc. | D To issuer deriv | 2019-02-15 | 2019-02-15 | 11,000 | $235.00 | $2.58M | 0 | SEC↗ |
| LOXO Loxo Oncology, Inc. | D To issuer deriv | 2019-02-15 | 2019-02-15 | 5,228 | $235.00 | $1.23M | 0 | SEC↗ |
| LOXO Loxo Oncology, Inc. | D To issuer deriv | 2019-02-15 | 2019-02-15 | 5,209 | $235.00 | $1.22M | 0 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2018-11-28 | 2018-11-30 | 110,000 | — | $0 | 110,000 | SEC↗ |
| LOXO Loxo Oncology, Inc. | A Award deriv | 2018-06-13 | 2018-06-14 | 8,750 | — | $0 | 8,750 | SEC↗ |
| LOXO Loxo Oncology, Inc. | M Exercise deriv | 2018-06-08 | 2018-06-11 | 2,584 | — | $0 | 5,228 | SEC↗ |
| LOXO Loxo Oncology, Inc. | M Exercise deriv | 2018-06-08 | 2018-06-11 | 7,416 | — | $0 | 5,209 | SEC↗ |
| LOXO Loxo Oncology, Inc. | S Sale | 2018-06-08 | 2018-06-11 | 10,000 | $179.55 | $1.80M | 0 | SEC↗ |
| LOXO Loxo Oncology, Inc. | M Exercise | 2018-06-08 | 2018-06-11 | 7,416 | $20.91 | $155.1K | 7,416 | SEC↗ |
| LOXO Loxo Oncology, Inc. | M Exercise | 2018-06-08 | 2018-06-11 | 2,584 | $24.18 | $62.5K | 10,000 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | M Exercise deriv | 2018-01-31 | 2018-02-01 | 1,939 | — | $0 | 0 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | M Exercise deriv | 2018-01-31 | 2018-02-01 | 2,610 | — | $0 | 0 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | M Exercise | 2018-01-31 | 2018-02-01 | 1,939 | $1.05 | $2.0K | 43,553 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | M Exercise | 2018-01-31 | 2018-02-01 | 2,610 | $1.26 | $3.3K | 46,163 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2018-01-02 | 2018-01-03 | 107,000 | — | $0 | 107,000 | SEC↗ |
| LOXO Loxo Oncology, Inc. | S Sale | 2017-12-20 | 2017-12-22 | 10,000 | $80.49 | $804.9K | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | A Award deriv | 2017-12-06 | 2017-12-08 | 35,000 | — | $0 | 35,000 | SEC↗ |
| LOXO Loxo Oncology, Inc. | M Exercise deriv | 2017-11-22 | 2017-11-27 | 3,000 | — | $0 | 12,625 | SEC↗ |
| LOXO Loxo Oncology, Inc. | M Exercise | 2017-11-22 | 2017-11-27 | 3,000 | $20.91 | $62.7K | 13,000 | SEC↗ |
| LOXO Loxo Oncology, Inc. | S Sale | 2017-11-22 | 2017-11-27 | 3,000 | $75.85 | $227.5K | 10,000 | SEC↗ |
| LOXO Loxo Oncology, Inc. | A Award deriv | 2017-06-22 | 2017-06-23 | 11,000 | — | $0 | 11,000 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2017-02-21 | 2017-02-22 | 171,100 | — | $0 | 171,100 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | A Award | 2017-01-17 | 2018-01-29 | 4,500 | — | $0 | 50,350 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | A Award deriv | 2017-01-17 | 2017-01-19 | 4,500 | — | $0 | 4,500 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | A Award deriv | 2017-01-17 | 2017-01-19 | 10,500 | — | $0 | 10,500 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2017-01-03 | 2017-01-03 | 140,000 | — | $0 | 140,000 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | A Award | 2016-08-03 | 2018-01-29 | 3,300 | — | $0 | 45,850 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | A Award deriv | 2016-08-03 | 2016-08-05 | 7,700 | — | $0 | 7,700 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | A Award deriv | 2016-08-03 | 2016-08-05 | 3,300 | — | $0 | 3,300 | SEC↗ |
| LOXO Loxo Oncology, Inc. | A Award deriv | 2016-06-10 | 2016-06-13 | 7,812 | — | $0 | 7,812 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | P Buy | 2016-05-04 | 2016-05-05 | 7,000 | $14.85 | $104.0K | 41,614 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | P Buy | 2016-01-27 | 2016-01-28 | 3,600 | $15.88 | $57.2K | 34,614 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | P Buy | 2016-01-15 | 2016-01-19 | 7,200 | $14.08 | $101.4K | 31,014 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2016-01-04 | 2016-01-05 | 30,000 | — | $0 | 22 | SEC↗ |
| LOXO Loxo Oncology, Inc. | A Award deriv | 2015-07-28 | 2015-07-30 | 15,625 | — | $0 | 15,625 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | A Award deriv | 2015-07-20 | 2015-07-22 | 6,300 | — | $0 | 6,300 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | M Exercise deriv | 2015-07-16 | 2015-07-17 | 15,515 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | M Exercise deriv | 2015-07-16 | 2015-07-17 | 27,035 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | M Exercise | 2015-07-16 | 2015-07-17 | 15,515 | $1.04 | $16.1K | 15,515 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | M Exercise | 2015-07-16 | 2015-07-17 | 27,035 | $1.04 | $28.1K | 42,550 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2015-03-18 | 2015-03-20 | 36,800 | — | $0 | 36,800 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2015-01-02 | 2015-01-06 | 92,000 | — | $0 | 92,000 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | A Award deriv | 2014-09-30 | 2014-10-02 | 6,000 | — | $0 | 6,000 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2013-12-20 | 2014-02-20 | 40,000 | — | $0 | 40,000 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2013-07-23 | 2013-07-25 | 190,000 | — | $0 | 190,000 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | P Buy | 2013-07-01 | 2013-07-01 | 5,000 | $14.00 | $70.0K | 28,814 | SEC↗ |
| ASTM AASTROM BIOSCIENCES INC | A Award deriv | 2012-08-29 | 2012-08-30 | 283,000 | $1.67 | $472.6K | 283,000 | SEC↗ |
| ASTM AASTROM BIOSCIENCES INC | D To issuer deriv | 2012-08-29 | 2012-08-30 | 317,000 | $1.49 | $472.3K | 78,000 | SEC↗ |
| ASTM AASTROM BIOSCIENCES INC | D To issuer deriv | 2012-06-25 | 2012-06-27 | 481,164 | $2.26 | $1.09M | 218,711 | SEC↗ |
| ASTM AASTROM BIOSCIENCES INC | A Award deriv | 2012-06-25 | 2012-06-27 | 481,164 | $2.26 | $1.09M | 481,164 | SEC↗ |
| ASTM AASTROM BIOSCIENCES INC | A Award deriv | 2012-05-03 | 2012-05-07 | 520,000 | $2.49 | $1.29M | 520,000 | SEC↗ |